Klotho Neurosciences, Inc. (NASDAQ:KLTOW) Sees Significant Growth in Short Interest

Klotho Neurosciences, Inc. (NASDAQ:KLTOW) was the recipient of a large increase in short interest during the month of February. As of February 13th, there was short interest totaling 58,583 shares, an increase of 20.2% from the January 29th total of 48,745 shares. Based on an average daily trading volume, of 12,406 shares, the short-interest ratio is currently 4.7 days. Based on an average daily trading volume, of 12,406 shares, the short-interest ratio is currently 4.7 days.

Klotho Neurosciences Trading Up 13.0%

Shares of KLTOW stock opened at $0.10 on Friday. The firm’s 50-day simple moving average is $0.09 and its 200-day simple moving average is $0.13. Klotho Neurosciences has a 1-year low of $0.01 and a 1-year high of $0.95.

Klotho Neurosciences is a clinical‐stage biotechnology company focused on developing innovative therapies that harness the neuroprotective and regenerative properties of the Klotho protein. The Klotho protein has been linked to neuronal health, longevity and resilience to various forms of cellular stress. By targeting pathways that increase or mimic Klotho activity in the central nervous system, the company aims to address a range of neurodegenerative and neuroinflammatory disorders.

The company’s pipeline includes both small-molecule candidates and engineered biologics designed to elevate Klotho levels in the brain or potentiate its signaling pathways.